We are live on ! Find out more
ACA

Aptus Capital Advisors Portfolio holdings

AUM $12.7B
1-Year Est. Return 17.41%
This Fund
S&P 500
This Quarter Est. Return
+0.62%
1 Year Est. Return
+17.41%
3 Year Est. Return
+53.41%
5 Year Est. Return
+57.81%
10 Year Est. Return
AUM
$9.55B
AUM Growth
+$2.85B
Cap. Flow
+$2.85B
Cap. Flow %
29.81%
Top 10 Hldgs %
24.75%
Holding
1,473
New
241
Increased
793
Reduced
193
Closed
63

Sector Composition

Rank Sector Weight
1 Technology 11.26%
2 Financials 5.55%
3 Consumer Discretionary 4.14%
4 Healthcare 3.78%
5 Industrials 3.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTAP icon
826
NetApp
NTAP
$35B
$247K ﹤0.01%
+2,131
New +$260K
EFIV icon
827
State Street SPDR S&P 500 ESG ETF
EFIV
$1,000M
$245K ﹤0.01%
4,340
+263
+6% +$15K
EXR icon
828
Extra Space Storage
EXR
$31.3B
$245K ﹤0.01%
1,638
+68
+4% +$11.2K
DG icon
829
Dollar General
DG
$28B
$244K ﹤0.01%
3,212
-720
-18% -$56.7K
NVG icon
830
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.68B
$243K ﹤0.01%
+19,781
New +$255K
HPQ icon
831
HP
HPQ
$24.9B
$242K ﹤0.01%
7,376
-1,320
-15% -$47.5K
VEU icon
832
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$241K ﹤0.01%
4,198
+3,521
+520% +$212K
PFG icon
833
Principal Financial Group
PFG
$24.3B
$241K ﹤0.01%
3,109
+344
+12% +$29K
MPWR icon
834
Monolithic Power Systems
MPWR
$70.1B
$240K ﹤0.01%
405
+97
+31% +$70.2K
DXCM icon
835
DexCom
DXCM
$31.5B
$240K ﹤0.01%
+3,083
New +$228K
GSK icon
836
GSK
GSK
$104B
$240K ﹤0.01%
7,015
-871
-11% -$31.4K
SHV icon
837
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
$238K ﹤0.01%
2,166
-1,346
-38% -$148K
TROW icon
838
T. Rowe Price
TROW
$23.9B
$238K ﹤0.01%
+2,108
New +$244K
BCI icon
839
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$2.95B
$238K ﹤0.01%
12,063
+641
+6% +$12.9K
FHN icon
840
First Horizon
FHN
$12.2B
$238K ﹤0.01%
+11,744
New +$221K
WST icon
841
West Pharmaceutical
WST
$24B
$238K ﹤0.01%
725
+3
+0.4% +$944
DEO icon
842
Diageo
DEO
$49B
$237K ﹤0.01%
1,867
+95
+5% +$12.1K
ISCB icon
843
iShares Morningstar Small-Cap ETF
ISCB
$282M
$237K ﹤0.01%
4,039
+80
+2% +$4.84K
PNR icon
844
Pentair
PNR
$10.4B
$237K ﹤0.01%
2,353
+303
+15% +$31.1K
HES
845
DELISTED
Hess
HES
$237K ﹤0.01%
+1,779
New +$248K
BN icon
846
Brookfield
BN
$104B
$236K ﹤0.01%
+6,149
New +$232K
WDAY icon
847
Workday
WDAY
$39.6B
$235K ﹤0.01%
+912
New +$233K
FDS icon
848
Factset
FDS
$9.36B
$234K ﹤0.01%
+488
New +$232K
VHT icon
849
Vanguard Health Care ETF
VHT
$18.1B
$234K ﹤0.01%
922
+272
+42% +$73.3K
AM icon
850
Antero Midstream
AM
$10.4B
$234K ﹤0.01%
15,494
-182
-1% -$2.77K

Similar funds

Aptus Capital Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Aptus Capital Advisors held 1,473 positions worth $9.55B, up 42% from $6.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Aptus Capital Advisors deployed $2.85B of net new capital in Q4 2024, opening 241 new positions and adding to 793 existing holdings. Its largest new stake was Fidelity MSCI Utilities Index ETF: 271,021 shares worth $13.2M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Invesco BulletShares 2026 Corporate Bond ETF, an estimated $95.2M trimmed.

  • Aptus Capital Advisors's largest Q4 2024 buy was Fidelity MSCI Utilities Index ETF: 271,021 shares worth $13.2M.
  • Aptus Capital Advisors added most to Aptus Collared Investment Opportunity ETF in Q4 2024, an estimated $116M increase.
  • Aptus Capital Advisors's biggest Q4 2024 reduction was Invesco BulletShares 2026 Corporate Bond ETF, cutting an estimated $95.2M.
  • Aptus Capital Advisors fully exited Old Second Bancorp in Q4 2024, selling an estimated $4.47M.
  • Aptus Capital Advisors's ten largest holdings make up 25% of its $9.55B portfolio in Q4 2024.
  • Aptus Capital Advisors opened 241 new positions and closed 63 in Q4 2024.
  • Aptus Capital Advisors's portfolio value rose 42% quarter-over-quarter to $9.55B.

Based on Aptus Capital Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.